Head and Neck Squamous Cell Carcinoma: NT5E Could Be a Prognostic Biomarker

Overview

Journal Appl Bionics Biomech

Publisher Wiley

Date 2022 May 5

PMID 35510041

Authors

Yaoting Zhang

Sultan Kadasah

Jiaheng Xie

Dongsheng Gu

Affiliations

Soon will be listed here.

Abstract

Head and neck squamous cell carcinoma (HNSCC) is a type of tumour with a relatively poor prognosis. In recent years, immune checkpoint inhibitors, such as CTLA-4 and PD-1/PDL-1 inhibitors, have improved the treatment status of advanced tumours. However, the emergence of drug resistance has brought difficulties to clinical treatment, and new immune checkpoint research is imminent. The hypoxia-adenosine pathway, in which CD73 encoded by the NT5E gene is a key enzyme for adenosine production, has been identified as an immune checkpoint of great potential. Therefore, NT5E may play an important role in HNSCC. We performed a detailed bioinformatics analysis of NT5E in HNSCC, and the results showed that the overexpression of NT5E in HNSCC was associated with poor prognosis. Our further investigation of the coexpression pattern of HNSCC could provide a reference for drug resistance and immunotherapy studies.

Citing Articles

Involvement of the Constitutive Photomorphogenesis 9 Signalosome Subunit 5 With Programmed Cell Death Protein 1 Ligand in Asthma.

Choi S, An M, Lee P, Hwang D, Nam Y, Park S Allergy Asthma Immunol Res. 2024; 16(5):505-519.

PMID: 39363769 PMC: 11450436. DOI: 10.4168/aair.2024.16.5.505.

5'-Ectonucleotidase CD73/NT5E supports EGFR-mediated invasion of HPV-negative head and neck carcinoma cells.

Shi E, Wu Z, Karaoglan B, Schwenk-Zieger S, Kranz G, Abdul Razak N J Biomed Sci. 2023; 30(1):72.

PMID: 37620936 PMC: 10463398. DOI: 10.1186/s12929-023-00968-6.

References

Buchbinder E, Desai A . CTLA-4 and PD-1 Pathways: Similarities, Differences, and Implications of Their Inhibition. Am J Clin Oncol. 2015; 39(1):98-106. PMC: 4892769. DOI: 10.1097/COC.0000000000000239. View

Paluch E, Aspalter I, Sixt M . Focal Adhesion-Independent Cell Migration. Annu Rev Cell Dev Biol. 2016; 32:469-490. DOI: 10.1146/annurev-cellbio-111315-125341. View

Chandrashekar D, Bashel B, Balasubramanya S, Creighton C, Ponce-Rodriguez I, Chakravarthi B . UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses. Neoplasia. 2017; 19(8):649-658. PMC: 5516091. DOI: 10.1016/j.neo.2017.05.002. View

Kim M, Min Y, Jang J, Park H, Lee S, Lee C . Single-cell RNA sequencing reveals distinct cellular factors for response to immunotherapy targeting CD73 and PD-1 in colorectal cancer. J Immunother Cancer. 2021; 9(7). PMC: 8276303. DOI: 10.1136/jitc-2021-002503. View

Meng F, Guo Z, Hu Y, Mai W, Zhang Z, Zhang B . CD73-derived adenosine controls inflammation and neurodegeneration by modulating dopamine signalling. Brain. 2019; 142(3):700-718. DOI: 10.1093/brain/awy351. View

Seiwert T, Zuo Z, Keck M, Khattri A, Pedamallu C, Stricker T . Integrative and comparative genomic analysis of HPV-positive and HPV-negative head and neck squamous cell carcinomas. Clin Cancer Res. 2014; 21(3):632-41. PMC: 4305034. DOI: 10.1158/1078-0432.CCR-13-3310. View

Ma X, Hu B, Tang W, Xie S, Ren N, Guo L . CD73 sustained cancer-stem-cell traits by promoting SOX9 expression and stability in hepatocellular carcinoma. J Hematol Oncol. 2020; 13(1):11. PMC: 7003355. DOI: 10.1186/s13045-020-0845-z. View

Rotte A . Combination of CTLA-4 and PD-1 blockers for treatment of cancer. J Exp Clin Cancer Res. 2019; 38(1):255. PMC: 6567914. DOI: 10.1186/s13046-019-1259-z. View

Qiu Y, Li H, Xie J, Qiao X, Wu J . Identification of ABCC5 Among ATP-Binding Cassette Transporter Family as a New Biomarker for Hepatocellular Carcinoma Based on Bioinformatics Analysis. Int J Gen Med. 2021; 14:7235-7246. PMC: 8560065. DOI: 10.2147/IJGM.S333904. View

10.

Solomon B, Young R, Rischin D . Head and neck squamous cell carcinoma: Genomics and emerging biomarkers for immunomodulatory cancer treatments. Semin Cancer Biol. 2018; 52(Pt 2):228-240. DOI: 10.1016/j.semcancer.2018.01.008. View

11.

Venuti A, Paolini F . HPV detection methods in head and neck cancer. Head Neck Pathol. 2012; 6 Suppl 1:S63-74. PMC: 3394157. DOI: 10.1007/s12105-012-0372-5. View

12.

Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z . GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017; 45(W1):W98-W102. PMC: 5570223. DOI: 10.1093/nar/gkx247. View

13.

Chen Q, Pu N, Yin H, Zhang J, Zhao G, Lou W . CD73 acts as a prognostic biomarker and promotes progression and immune escape in pancreatic cancer. J Cell Mol Med. 2020; 24(15):8674-8686. PMC: 7412695. DOI: 10.1111/jcmm.15500. View

14.

Li T, Fan J, Wang B, Traugh N, Chen Q, Liu J . TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells. Cancer Res. 2017; 77(21):e108-e110. PMC: 6042652. DOI: 10.1158/0008-5472.CAN-17-0307. View

15.

von Mering C, Huynen M, Jaeggi D, Schmidt S, Bork P, Snel B . STRING: a database of predicted functional associations between proteins. Nucleic Acids Res. 2003; 31(1):258-61. PMC: 165481. DOI: 10.1093/nar/gkg034. View

16.

Gao Z, Dong K, Zhang H . The roles of CD73 in cancer. Biomed Res Int. 2014; 2014:460654. PMC: 4121992. DOI: 10.1155/2014/460654. View

17.

Leonard B, Brand T, OKeefe R, Lee E, Zeng Y, Kemmer J . BET Inhibition Overcomes Receptor Tyrosine Kinase-Mediated Cetuximab Resistance in HNSCC. Cancer Res. 2018; 78(15):4331-4343. PMC: 6072571. DOI: 10.1158/0008-5472.CAN-18-0459. View

18.

Leone R, Emens L . Targeting adenosine for cancer immunotherapy. J Immunother Cancer. 2018; 6(1):57. PMC: 6006764. DOI: 10.1186/s40425-018-0360-8. View

19.

Economopoulou P, Agelaki S, Perisanidis C, Giotakis E, Psyrri A . The promise of immunotherapy in head and neck squamous cell carcinoma. Ann Oncol. 2016; 27(9):1675-85. DOI: 10.1093/annonc/mdw226. View

20.

Leemans C, Snijders P, Brakenhoff R . The molecular landscape of head and neck cancer. Nat Rev Cancer. 2018; 18(5):269-282. DOI: 10.1038/nrc.2018.11. View